drugset / Trial / NCT06854393

Summary

The objective of this study is to evaluate the safety and effectiveness of Lacripep as a therapy for superficial corneal injury repair after Photorefractive keratectomy (PRK).

Timeline

Start
2025-05-23
Primary completion
2027-06
Completion
2027-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacripep Unknown 0.00025 % Other

Indications